19 June 2013
Keywords: fda, extends, review, sanofi-aventis, anti-obesity, drug, acomplia
Article | 19 February 2007
French drugmaker Sanofi-Aventis says that the US Food and Drug Administration has decided to extend its review of the anti-obesity ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 February 2007
18 June 2013
© 2013 thepharmaletter.com